These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7773641)

  • 1. Tissue inhibitor of the metalloproteinases and renal extracellular matrix accumulation.
    Jones CL; Fecondo J; Kelynack K; Forbes J; Walker R; Becker G
    Exp Nephrol; 1995; 3(2):80-6. PubMed ID: 7773641
    [No Abstract]   [Full Text] [Related]  

  • 2. Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis.
    Norman JT; Gatti L; Wilson PD; Lewis M
    Exp Nephrol; 1995; 3(2):88-9. PubMed ID: 7773643
    [No Abstract]   [Full Text] [Related]  

  • 3. A Mr 21,000 inhibitor of matrix metalloproteinases from human fibroblasts.
    Moore WG; Birkedal-Hansen B; Pierson M; Birkedal-Hansen H
    Matrix Suppl; 1992; 1():319-20. PubMed ID: 1480050
    [No Abstract]   [Full Text] [Related]  

  • 4. Collagen turnover in renal disease.
    Costigan M; Chambers DA; Boot-Handford RP
    Exp Nephrol; 1995; 3(2):114-21. PubMed ID: 7773630
    [No Abstract]   [Full Text] [Related]  

  • 5. Matrix metalloproteinases and their inhibitors.
    Murphy G
    Acta Orthop Scand Suppl; 1995 Oct; 266():55-60. PubMed ID: 8553862
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial macrophages as mediators of renal fibrosis.
    Eddy AA
    Exp Nephrol; 1995; 3(2):76-9. PubMed ID: 7773640
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures.
    Roeb E; Graeve L; Hoffmann R; Decker K; Edwards DR; Heinrich PC
    Hepatology; 1993 Dec; 18(6):1437-42. PubMed ID: 8244270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis, experimental manipulation and treatment of liver fibrosis.
    Arthur MJ
    Exp Nephrol; 1995; 3(2):90-5. PubMed ID: 7773644
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.
    Iredale JP; Benyon RC; Arthur MJ; Ferris WF; Alcolado R; Winwood PJ; Clark N; Murphy G
    Hepatology; 1996 Jul; 24(1):176-84. PubMed ID: 8707259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The matrix-degrading metalloproteinases.
    Matrisian LM
    Bioessays; 1992 Jul; 14(7):455-63. PubMed ID: 1445287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of matrix metalloproteinase activity.
    Murphy G; Willenbrock F; Crabbe T; O'Shea M; Ward R; Atkinson S; O'Connell J; Docherty A
    Ann N Y Acad Sci; 1994 Sep; 732():31-41. PubMed ID: 7978800
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis.
    Morrissey JJ; Ishidoya S; McCracken R; Klahr S
    Kidney Int Suppl; 1996 May; 54():S83-7. PubMed ID: 8731201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases. A mini-review.
    Nagase H
    Contrib Nephrol; 1994; 107():85-93. PubMed ID: 8004978
    [No Abstract]   [Full Text] [Related]  

  • 16. The regulation of connective tissue metalloproteinases by natural inhibitors.
    Murphy G
    Agents Actions Suppl; 1991; 35():69-76. PubMed ID: 1781423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies.
    Reynolds JJ; Meikle MC
    J R Coll Surg Edinb; 1997 Jun; 42(3):154-60. PubMed ID: 9195805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.
    Herbst H; Wege T; Milani S; Pellegrini G; Orzechowski HD; Bechstein WO; Neuhaus P; Gressner AM; Schuppan D
    Am J Pathol; 1997 May; 150(5):1647-59. PubMed ID: 9137090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix abnormalities in testis and epididymis of XXSxr ("sex-reversed") mice.
    Griffin JK; Blecher SR
    Mol Reprod Dev; 1994 May; 38(1):1-8. PubMed ID: 8049059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human stromelysin by peptides based on the N-terminal domain of tissue inhibitor of metalloproteinases-1.
    Hanglow AC; Lugo A; Walsky R; Visnick M; Coffey JW; Fotouhi N
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1156-63. PubMed ID: 7802645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.